Diagnostic accuracy of the Copenhagen Index in ovarian malignancy: A meta-analysis

PLoS One. 2023 Jun 14;18(6):e0286650. doi: 10.1371/journal.pone.0286650. eCollection 2023.

Abstract

Objective: To assess the diagnostic value of the Copenhagen index for ovarian malignancy.

Methods: PubMed, Web of Science, the Cochrane Library, Embase, CBM, CNKI, and WanFang databases were searched throughout June 2021. Statistical analyses were performed using Stata 12, Meta-DiSc, and RevMan 5.3. The pooled sensitivity, specificity, and diagnostic odds ratio were calculated, the summary receiver operating characteristic curve was drawn, and the area under the curve was calculated.

Results: Ten articles, including 11 studies with a total of 5266 patients, were included. The pooled sensitivity, specificity, and diagnostic odds ratio were 0.82 [95% CI (0.80-0.83)], 0.88 [95% CI (0.87-0.89)], and 57.31 [95% CI (32.84-100.02)], respectively. The area under the summary receiver operating characteristics curve and the Q index were 0.9545 and 0.8966, respectively.

Conclusion: Our systematic review shows that the sensitivity and specificity of the Copenhagen index are high enough for it to be used in a clinical setting to provide accurate ovarian cancer diagnosis without considering menopausal status.

Publication types

  • Systematic Review
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Databases, Factual
  • Female
  • Gene Library
  • Humans
  • Libraries*
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / epidemiology

Grants and funding

This work was supported by the National Natural Science Foundation of China (grant no. 81560426), the Key Discipline Project of Gansu Provincial Hospital (grant no. 20GSSY1-4).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.